<p>Dots represent the median serum WFA<sup>+</sup>-M2BP values at each time point, and the error bar represents the interquartile range. Diamonds represent the median serum AFP values at each time point, and the error bar represents the interquartile range. (A): Patients who developed HCC (n = 16). WFA<sup>+</sup>-M2BP values were decreased at post-treatment and increased at HCC development. And AFP values were decreased at post-treatment and increased at HCC development. (B): Patients who did not developed HCC (n = 222). WFA<sup>+</sup>-M2BP values were decreased at post-treatment and last clinical visit. And AFP values were decreased at post-treatment and last clinical visit.</p
<p>Left axis illustrates the percentage of AF patients having an event within the first year. Right ...
<p>(<b>A</b>) Kinetics of plasma HCV-RNA and ALT levels until 15–24 months from clinical onset of in...
<p>(A) Serum DCP and AFP levels in HCC before and after radical partial hepatectomy therapy. (B) Ser...
<p>The distribution of WFA<sup>+</sup>-M2BP values was plotted. The dashed line indicates the 2.0 CO...
<p>(A) Dynamic changes of AFP-L3% in each HCC patient. The results of the assay showed that AFP-L3% ...
<p><b>Changes in serum levels of (A) HCV RNA, (B) ALT, (C) ATX, (D) FIB-4 index, and (E) APRI before...
<p>Change in serum (a) WHsAg and (b) WHV DNA relative to week -3 (pre-treatment baseline). Circles i...
<p>Box plots represent the reduction rate of CXCL10 (panel A), sCD163 (panel B) and sCD14 (panel C) ...
<p>Cumulative incidences of HCC according to post-treatment WFA<sup>+</sup>-M2BP values were analyze...
<p>N/A: not applicable.</p><p><sup>a</sup>Treatment response groups were defined as follows: R, resp...
<p>Abbreviations: human papillomavirus (HPV); number (N); standard deviation (STD); interquartile ra...
<p>(A) Patients with abnormal liver functions had significantly higher incidence of HCC than those w...
<p>Blue bars: assume that 140 per 1000 PWIDs are tested and that 8, 20, 40 and 80 per 1000 PWID are ...
<p>Bubble plot of cumulative number of HBV pre-S point mutations associated with HCC at 4 time point...
<p>Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before a...
<p>Left axis illustrates the percentage of AF patients having an event within the first year. Right ...
<p>(<b>A</b>) Kinetics of plasma HCV-RNA and ALT levels until 15–24 months from clinical onset of in...
<p>(A) Serum DCP and AFP levels in HCC before and after radical partial hepatectomy therapy. (B) Ser...
<p>The distribution of WFA<sup>+</sup>-M2BP values was plotted. The dashed line indicates the 2.0 CO...
<p>(A) Dynamic changes of AFP-L3% in each HCC patient. The results of the assay showed that AFP-L3% ...
<p><b>Changes in serum levels of (A) HCV RNA, (B) ALT, (C) ATX, (D) FIB-4 index, and (E) APRI before...
<p>Change in serum (a) WHsAg and (b) WHV DNA relative to week -3 (pre-treatment baseline). Circles i...
<p>Box plots represent the reduction rate of CXCL10 (panel A), sCD163 (panel B) and sCD14 (panel C) ...
<p>Cumulative incidences of HCC according to post-treatment WFA<sup>+</sup>-M2BP values were analyze...
<p>N/A: not applicable.</p><p><sup>a</sup>Treatment response groups were defined as follows: R, resp...
<p>Abbreviations: human papillomavirus (HPV); number (N); standard deviation (STD); interquartile ra...
<p>(A) Patients with abnormal liver functions had significantly higher incidence of HCC than those w...
<p>Blue bars: assume that 140 per 1000 PWIDs are tested and that 8, 20, 40 and 80 per 1000 PWID are ...
<p>Bubble plot of cumulative number of HBV pre-S point mutations associated with HCC at 4 time point...
<p>Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before a...
<p>Left axis illustrates the percentage of AF patients having an event within the first year. Right ...
<p>(<b>A</b>) Kinetics of plasma HCV-RNA and ALT levels until 15–24 months from clinical onset of in...
<p>(A) Serum DCP and AFP levels in HCC before and after radical partial hepatectomy therapy. (B) Ser...